SUBSCRIBE
SUBSCRIBE
News   FDA

Roche’s Tamiflu Gets EU Approval For Use On Children

January 31, 2006 | 
1 min read
Tamiflu, the anti-influenza drug being stockpiled around the world as a potential defence against bird flu, has received approval to be used for children aged one to twelve in the European Union.
FDA Approvals Europe
Roche
MORE ON THIS TOPIC
Regulatory
RFK Jr. Joins Deputies in Voicing Support for Regulatory Flexibility for Cell and Gene Therapies
June 6, 2025
 · 
2 min read
 · 
Tristan Manalac
IN PARTNERSHIP WITH IQVIA
AI’s Role in Decoding the FDA’s New Regulatory Communications
June 5, 2025
 · 
1 min read
 · 
Lori Ellis
Courtesy of Sarepta Therapeutics
Gene therapy
Sarepta Wins FDA’s Platform Technology Designation, Marking ‘Critical Shift’ in Gene Therapy Development
June 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Rare diseases
FDA’s Prasad Vows To Make Rare Disease Drugs Available at ‘First Sign of Promise’
June 4, 2025
 · 
2 min read
 · 
Nick Paul Taylor